Tuesday, November 14, 2017 10:15 PM ET
Insider Selling in Biohaven Pharmaceutical Holding (BHVN) Shares Continues
There was a notable sale of shares of Biohaven Pharmaceutical Holding by an insider today, as indicated in a form 4 document filed with the SEC. One insider — Robert Berman, Officer — sold 160,000 shares in the company having a market value of approximately $4,122,064. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 123,950 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 283,950 shares and have averaged 141,975 shares per transaction over this time period.
The number of insider buy/sell trades at Biohaven Pharmaceutical Holding is greater than that of the 186 peer company average over the last 90-day period. The Biotechnology & Medical Research peer group saw 202 buy/sell trades during this period for an average of 1.1 transactions per company. However, the number of shares traded per transaction by Biohaven Pharmaceutical Holding insiders is lower than its peers. Within the peer group there were 23,127,803 shares purchased and 51,287,733 shares sold with company insiders having sold 139,406 shares on average over this time period.
In order to focus on significant insider buying and selling activity, all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers has been eliminated data sourced to compose and write this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2017 UpTick Data Technologies. All rights reserved.